Deputy director of Texas Children’s Cancer Center Dr. Susan Blaney recently was appointed to the hematology-oncology self-assessment team of the American Board of Pediatrics (ABP). In this role, Blaney will develop content for Maintenance of Certification exams, one component of which is self-assessment.
Founded in 1933, the ABP is one of the 24 certifying boards of the American Board of Medical Specialties. The ABP is an independent, nonprofit organization whose certificate is recognized throughout the world as a credential signifying a high level of physician competence.
In addition to her duties with the Cancer Center, Blaney is executive vice chair of the Department of Pediatrics at Baylor College of Medicine. She also is the vice chair of the Children’s Oncology Group, the National Cancer Institute supported clinical trials group and the world’s largest organization devoted exclusively to pediatric cancer research.
Blaney served as the co-director of the Developmental Therapeutics Program at Texas Children’s Cancer Center where she performs pre-clinical and clinical studies of new antineoplastic agents. A primary focus of her research is the development of new drugs for the treatment of central nervous system tumors in children with a particular emphasis on the development of new agents for intrathecal administration.